Fiducial Markers market is expected to grow from USD 0.10 billion in 2019 to USD 0.14 billion by 2026 at a CAGR of 5% from 2020 to 2026.
Fiducial marker is a medical device which is typically placed on the body or object in order that it can mark the world that require to urge surgery. This device has the power to mark the precise position of the tumour and help the doctor to supply maximum radiation dose to the tumour without harming the tissues. There are differing types of fiducial marker like metal-based marker, polymer-based marker etc. They are generally used in disease site like breast, lung, abdomen, kidney etc.
Fiducial markers are placed in or near tumour during the radiotherapy process to locate the tumour for providing accurate radiation dosage. There are several technological advancements to develop advanced navigation system for correct placement of the merchandise. As an example, SPiN System’s a complicated navigation technology by Veran Medical Technologies helps locate the target to put the fiducial marker appropriately for radiation or resection. This technology also provides 3D view of fiducials and generates the report for correct diagnosis and treatment.
The global Fiducial Markers market is segregated on the basis of Product as Metal-based Markers, Polymer-based Markers, and Other Fiducial Markers. Based on Modality the global Fiducial Markers market is segmented in CT/CBCT, MRI, Ultrasound, and Radiotherapy. Based on Cancer Type the global Fiducial Markers market is segmented in Prostate Cancer, Lung Cancer, Breast Cancer, Gastric Cancer, and Other Cancers.
Based on End User, the global Fiducial Markers market is segmented in Hospitals & Outpatient Facilities, Independent Radiotherapy Centers, and Cancer Research Centers.
The global Fiducial Markers market report provides geographic analysis covering regions, such as The Fiducial Markers market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
CIVCO Radiotherapy, Boston Scientific Corporation, IZI Medical Products, IBA, Naslund Medical AB, Medtronic, Best Medical International, Inc., Nanovi A/S, Carbon Medical Technologies, Eckert & Ziegler, and others are among the major players in the global Fiducial Markers market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Fiducial Markers market has been segmented as below:
Fiducial Markers Market, By Product
Fiducial Markers Market, By Modality
Fiducial Markers Market, By Cancer Type
Fiducial Markers Market, By End User
Fiducial Markers Market, By Region
Fiducial Markers Market, By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global Fiducial Markers market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Fiducial Markers market share. Major industry players with significant revenue share include CIVCO Radiotherapy, Boston Scientific Corporation, IZI Medical Products, IBA, Naslund Medical AB, Medtronic, Best Medical International, Inc., Nanovi A/S, Carbon Medical Technologies, Eckert & Ziegler, and others.
Why to Buy this Report:
Target Audience:
The report targeted towards the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5.1 Introduction
5.2 Metal-based Markers
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Polymer-based Markers
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Other Fiducial Markers
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6.1 Introduction
6.2 CT/CBCT
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 MRI
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Ultrasound
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Radiotherapy
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7.1 Introduction
7.2 Prostate Cancer
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Lung Cancer
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Breast Cancer
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Gastric Cancer
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Other Cancers
7.6.1 Market Overview
7.6.2 Market Size and Forecast
8.1 Introduction
8.2 Hospitals & Outpatient Facilities
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Independent Radiotherapy Centers
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Cancer Research Centers
8.4.1 Market Overview
8.4.2 Market Size and Forecast
9.1 Introduction
9.2 Europe
9.2.1 Europe Fiducial Markers, By Product
9.2.2 Europe Fiducial Markers, By Modality
9.2.3 Europe Fiducial Markers, By Cancer Type
9.2.4 Europe Fiducial Markers, By End User
9.3 North America
9.3.1 North America Fiducial Markers, By Product
9.3.2 North America Fiducial Markers, By Modality
9.3.3 North America Fiducial Markers, By Cancer Type
9.3.4 North America Fiducial Markers, By End User
9.4 Asia Pacific
9.4.1 Asia Pacific Fiducial Markers, By Product
9.4.2 Asia Pacific Fiducial Markers, By Modality
9.4.3 Asia Pacific Fiducial Markers, By Cancer Type
9.4.4 Asia Pacific Fiducial Markers, By End User
9.5 Rest of The World
9.5.1 Rest of The World Fiducial Markers, By Product
9.5.2 Rest of The World Fiducial Markers, By Modality
9.5.3 Rest of The World Fiducial Markers, By Cancer Type
9.5.4 Rest of The World Fiducial Markers, By End User
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
(Overview, Key Financials, Recent Developments, Product and Service Offering)
The global Fiducial Markers market has been segmented as below:
Fiducial Markers Market, By Product
Fiducial Markers Market, By Modality
Fiducial Markers Market, By Cancer Type
Fiducial Markers Market, By End User
Fiducial Markers Market, By Region
Fiducial Markers Market, By Company